Glaxosmithkline Biologicals S.a. competitive analysis

Explore patent oppositions filed by Glaxosmithkline Biologicals S.a. against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 20, 2026
Patent NumberTitleApplicantOpposition Date
Agent For Locally Treating Cervical DysplasiasCHARIT UNIVERSITTSMEDIZIN BERLINDec 21, 2017

Explore Glaxosmithkline Biologicals S.a.'s recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 20, 2026
Patent NumberPublication DateTitleTotal Oppositions
Feb 26, 2025Rsv Immunization Regimen1
Feb 26, 2025Rsv Immunization Regimen1
Oct 23, 2024Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna5
Nov 29, 2023Expression System1
Jan 11, 2023Small Liposomes For Delivery Of Immunogen-Encoding Rna5
Dec 28, 2022Small Liposomes For Delivery Of Immunogen-Encoding Rna5
Dec 28, 2022Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna4
Dec 21, 2022Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna4
Dec 7, 2022Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna4
Oct 12, 2022Virion-Like Delivery Particles For Self-Replicating Rna Molecules2

Latest PTAB cases involving Glaxosmithkline Biologicals S.a.

Discover the latest PTAB cases involving Glaxosmithkline Biologicals S.a., highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Glaxosmithkline Biologicals S.a. with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 20, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GLAXOSMITHKLINE2912263
PFIZER541004412
SANOFI6425 - -
WEICKMANN & WEICKMANN56 - - -